Insider Trading activities of Oncothyreon Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Oncothyreon Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Oncothyreon Inc. since year 2005. Table 2 shows the detailed insider transactions of Oncothyreon Inc. since 2005. The reporting company's ticker symbol is CASC. The reporting company's CIK number is 1412067.
The total value of stock buying since 2005 is $2,875,160.
The total value of stock sales since 2005 is $283,487.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Oncothyreon Inc. (CASC).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 0 $0 0 $0 9,500 $0
2017-08 5,500 $20,542 0 $0 0 $0
2017-06 0 $0 0 $0 53,882 $0
2017-05 2,800 $11,191 0 $0 0 $0
2017-03 4,666 $19,012 0 $0 4,656 $0
2017-02 23,000 $97,520 0 $0 0 $0
2017-01 45,824 $181,019 0 $0 0 $0
2016-08 45,000 $51,749 0 $0 0 $0
2016-06 62,500 $50,000 0 $0 0 $0
2015-09 0 $0 0 $0 17,341 $0
2015-06 5,747 $26,723 0 $0 32,084 $0
2015-03 20,000 $32,130 0 $0 0 $0
2014-12 378,444 $688,685 0 $0 0 $0
2014-06 0 $0 0 $0 16,042 $0
2014-03 0 $0 0 $0 77,408 $0
2013-11 129,000 $229,620 0 $0 0 $0
2013-08 416,705 $708,622 0 $0 0 $0
2013-07 179,743 $307,360 3,403 $5,853 0 $0
2013-06 214,467 $387,187 0 $0 0 $0
2013-02 0 $0 12,780 $25,048 0 $0
2012-05 0 $0 0 $0 2,967 $0
2011-12 0 $0 0 $0 32,164 $0
2011-10 0 $0 0 $0 50,000 $0
2011-06 0 $0 28,900 $252,586 8,304 $0
2010-12 0 $0 0 $0 9,498 $0
2010-09 5,100 $17,411 0 $0 0 $0
2009-08 5,000 $25,335 0 $0 0 $0
2008-02 5,000 $13,000 0 $0 0 $0
2008-01 4,450 $8,054 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Oncothyreon Inc. insiders (CASC)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-24 James Steven P (Director) Option Ex 2,375 .00 0
2017-09-24 Henney Christopher S (Director) Option Ex 2,375 .00 0
2017-09-24 Spiegelman Daniel K (Director) Option Ex 2,375 .00 0
2017-09-24 Love Ted W (Director) Option Ex 2,375 .00 0
2017-08-11 Myers Scott Dunseth (President and CEO) Buy 5,500 3.73 20,542
2017-06-24 Fyfe Gwen A. (Director) Option Ex 9,058 .00 0
2017-06-24 James Steven P (Director) Option Ex 9,058 .00 0
2017-06-24 Henney Christopher S (Director) Option Ex 9,058 .00 0
2017-06-24 Spiegelman Daniel K (Director) Option Ex 9,058 .00 0
2017-06-24 Love Ted W (Director) Option Ex 9,058 .00 0
2017-06-12 James Steven P (Director) Option Ex 2,148 .00 0
2017-06-12 Henney Christopher S (Director) Option Ex 2,148 .00 0
2017-06-12 Spiegelman Daniel K (Director) Option Ex 2,148 .00 0
2017-06-12 Love Ted W (Director) Option Ex 2,148 .00 0
2017-05-12 Myers Scott Dunseth (President and CEO) Buy 2,800 4.00 11,191
2017-03-31 Myers Scott Dunseth (President and CEO) Buy 2,000 4.11 8,228
2017-03-28 Fyfe Gwen A. (Director) Buy 1,666 4.12 6,857
2017-03-20 Myers Scott Dunseth (President and CEO) Buy 1,000 3.93 3,927
2017-03-12 James Steven P (Director) Option Ex 4,656 .00 0
2017-02-02 Love Ted W (Director) Buy 23,000 4.24 97,520
2017-01-30 Henney Christopher S (Director) Buy 25,324 4.11 103,980
2017-01-27 Myers Scott Dunseth (President and CEO) Buy 20,500 3.76 77,039
2016-08-17 Myers Scott Dunseth (President and CEO) Buy 45,000 1.15 51,749
2016-06-28 Myers Scott Dunseth (President and CEO) Buy 62,500 .80 50,000
2015-09-05 Love Ted W (Director) Option Ex 17,341 .00 0
2015-06-13 Jackson Richard L. (Director) Option Ex 16,042 .00 0
2015-06-13 Spiegelman Daniel K (Director) Option Ex 16,042 .00 0
2015-06-01 Hausman Diana (Chief Medical Officer) Buy 5,747 4.65 26,723
2015-03-26 Spiegelman Daniel K (Director) Buy 10,000 1.59 15,860
2015-03-25 Spiegelman Daniel K (Director) Buy 10,000 1.63 16,270
2014-12-17 Lampert Mark N Buy 153,495 1.73 266,006
2014-12-15 Lampert Mark N Buy 224,949 1.88 422,679
2014-06-13 Henney Christopher S (Director) Option Ex 16,042 .00 0
2014-03-11 Jackson Richard L. (Director) Option Ex 19,352 .00 0
2014-03-11 Henney Christopher S (Director) Option Ex 19,352 .00 0
2014-03-11 Spiegelman Daniel K (Director) Option Ex 19,352 .00 0
2014-03-11 Stoughton W. Vickery (Director) Option Ex 19,352 .00 0
2013-11-01 Lampert Mark N (10% Owner) Buy 129,000 1.78 229,620
2013-08-08 Lampert Mark N (10% Owner) Buy 258,361 1.65 426,295
2013-08-01 Lampert Mark N (10% Owner) Buy 158,344 1.78 282,327
2013-07-31 Lampert Mark N (10% Owner) Buy 179,743 1.71 307,360
2013-07-10 Spiegelman Daniel K (Director) Sale 3,403 1.72 5,853
2013-06-07 Lampert Mark N (10% Owner) Buy 116,252 1.83 212,741
2013-06-06 Lampert Mark N (10% Owner) Buy 82,915 1.78 147,671
2013-06-05 Lampert Mark N (10% Owner) Buy 15,300 1.75 26,775
2013-02-20 Spiegelman Daniel K (Director) Sale 12,780 1.96 25,048
2012-05-03 Jackson Richard L. Option Ex 989 .00 0
2012-05-03 Henney Christopher S Option Ex 989 .00 0
2012-05-03 Stoughton W. Vickery Option Ex 989 .00 0
2011-12-31 Jackson Richard L. Option Ex 2,388 .00 0
2011-12-31 Henney Christopher S Option Ex 2,388 .00 0
2011-12-31 Stoughton W. Vickery Option Ex 2,388 .00 0
2011-12-01 Henney Christopher S Option Ex 25,000 .00 0
2011-10-10 Henney Christopher S Option Ex 50,000 .00 0
2011-06-23 Ayer Capital Management, Lp Sale 28,900 8.74 252,586
2011-06-12 Jackson Richard L. (Director) Option Ex 2,076 .00 0
2011-06-12 Henney Christopher S (Director) Option Ex 2,076 .00 0
2011-06-12 Spiegelman Daniel K (Director) Option Ex 2,076 .00 0
2011-06-12 Stoughton W. Vickery (Director) Option Ex 2,076 .00 0
2010-12-14 Jackson Richard L. (Director) Option Ex 3,166 .00 0
2010-12-14 Henney Christopher S (Director) Option Ex 3,166 .00 0
2010-12-14 Stoughton W. Vickery (Director) Option Ex 3,166 .00 0
2010-09-28 Karan Shashi K. (Corporate Controller) Buy 5,100 3.41 17,411
2009-08-18 Karan Shashi K. (Corporate Controller) Buy 5,000 5.07 25,335
2008-02-12 Jackson Richard L. Buy 5,000 2.60 13,000
2008-01-18 Taylor Edward A. (CFO, VP Fin Admin, Sec) Buy 4,450 1.81 8,054

Insider trading activities including stock purchases, stock sales, and option exercises of CASC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Oncothyreon Inc. (symbol CASC, CIK number 1412067) see the Securities and Exchange Commission (SEC) website.